Technology Name | Briefcase | Lead Researcher |
---|---|---|
Chip scale photonics technology is developing rapidly for diverse applications, from communication and computation to various types of sensing. The Levy group has pioneered diverse advanced chip scale photonic technologies, including for ... More | Levy Uriel | |
Step One: “Smart” micro - or nano-particles carrying inhibitors of the gene machinery in pathogens are developed.
Step Two: In the presence of biomarkers, the inhibiting agents are released, leading to the localized destruction of the ... More | Willner Itamar | |
Professors Willner and Pikarsky are developing masks and possible ventilation systems that will contain virus neutralizing properties. They have undertaken the development of matrices that neutralize pathogens which can be incorporated into ... More | Willner Itamar | |
Pneumonia caused by the new coronavirus SARS-CoV-2 has caused serious damage to people’s lives and health. The initial route of infection is the binding of the spike protein (S protein) of the virus to the angiotensin-converting enzyme 2 ... More | Gilon Chaim | |
This study will test the hypothesis that treatment with a peptide comprising five units (5-MER), which is administered by injection or oral delivery, will substantially reduce chronic inflammation of the upper respiratory tract and lungs, thus ... More | Naor David | |
Early, rapid, mobile, widespread and cheap detection of viral infection in humans is crucial in the battle against Corona, the worst epidemic of the last one hundred years. The virus is characterized by a specific single strand RNA and its ... More | Porath Danny | |
The goal of this project is to develop environmentally-friendly and non-toxic coating that would prevent the adhesion of viruses.
My research group developed a peptide-based coating that prevents adhesion of proteins to surfaces when then ... More | Reches Meital | |
We compare the interaction between the human ACE2 receptor and the SARS-CoV-2 spike protein with that of other pathogenic coronaviruses using molecular dynamics simulations.
Molecular dynamics simulations reveal a temporal dimension of ... More | Linial Michal | |
Our laboratory has previously generated fusion proteins of a wide range of viral entry receptors. Among these is ACE2, a membrane-bound enzyme which also serves as the entry receptor for the SARS virus. Study of the novel coronavirus discovered ... More | Mandelboim Ofer | |
Increased blood vessel permeability and vascular leak are a final common pathway in severe influenza and other fatal diseases, such as MERS, Ebola, Coronavirus and sepsis.
We have developed at the Hebrew U.- Hadassah Medical School( Prof. ... More | Ben-Sasson Shmuel | |
Our group has published a lot of work on the SARS Coronavirus. We were the first to characterize an important protein in the virus that has a very unusual structure and sequence (E protein). Moreover, this protein was unique to SARS and was not ... More | Arkin Isaiah | |
Our Innovative Approach
The genetic revolution which has taken place in recent years brings new opportunities to the field of drug discovery & repositioning. Using advanced comparative genomic, and data integration, our lab has been ... More | Tabach Yuval | |
We offer a fast and efficient diagnostic method which can be applied to a large amount of tests in a short time.
Our method is based on a kit which identifies specifically the viral RNA biomarker.
The test is characterized by reliability, ... More | Yavin Eylon | |
COVID-19
Pepticom is implementing its proprietary core AI technology on various Coronavirus proteins and the ACE2 to identify novel inhibitors that can fight Sars Cov2. They are currently looking for partners to validate and develop these ... More | Goldblum Amiram | |
COVID-19
Enlivex: Has developed a medication that could help treat severe symptoms of covid-19 including catastrophic organ failure.
Company Name
Enliex
Year Company was Founded
2005
About the Company
Enlivex Therapeutics R&D, a ... More | Linial Michal |
- 1
- 2